ABSTRACT
Vitreous hemorrhage is one of the most common causes of sudden, painless loss of vision in adults. This is probably one of the reasons why it has been extensively studied and reported in literature. However, the same cannot be said when it comes to vitreous hemorrhage in the pediatric age group. The causes of vitreous hemorrhage in children tend to differ from those of adults. Not much data exist regarding their presentation and management. In addition to trauma, certain spontaneous causes such as pediatric tumors and congenital conditions assume importance while considering the differential diagnosis of vitreous hemorrhage in the pediatric age group. However, it is natural that the treating ophthalmologist is faced with challenges when a child presents with vitreous hemorrhage. In this narrative review, we have attempted to analyze the retrospective observational studies regarding pediatric vitreous hemorrhage reported in English literature till date. The article sheds some light on the prevailing epidemiology, management strategies employed and the visual outcome among different regions of the world.
Subject(s)
Disease Management , Visual Acuity , Vitreous Body/diagnostic imaging , Vitreous Hemorrhage , Child , Global Health , Humans , Morbidity/trends , Vitreous Hemorrhage/diagnosis , Vitreous Hemorrhage/epidemiology , Vitreous Hemorrhage/therapySubject(s)
Aneurysm/drug therapy , Arteriovenous Fistula/complications , Neurocutaneous Syndromes/complications , Ranibizumab/administration & dosage , Retinal Artery , Visual Acuity , Aneurysm/diagnosis , Aneurysm/etiology , Angiogenesis Inhibitors/administration & dosage , Arteriovenous Fistula/diagnosis , Arteriovenous Fistula/drug therapy , Exudates and Transudates , Female , Fluorescein Angiography/methods , Follow-Up Studies , Fundus Oculi , Humans , Intravitreal Injections , Neurocutaneous Syndromes/diagnosis , Neurocutaneous Syndromes/drug therapy , Tomography, Optical Coherence/methods , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Young AdultABSTRACT
A 23-year male with complaint of diminution of vision in left eye was referred to us as a suspect case of inflammatory choroidal mass/melanoma. Examination revealed a total retinal detachment with a reddish brown lesion in the superior hemi-fundus. B-scan ultrasonography demonstrated the 'mass' to be intra-retinal without choroidal involvement. A diagnosis of haemorrhagic intraretinal macrocyst (HIM) was made. We report this case to highlight the importance of correctly diagnosing an HIM and utilizing ultrasound to rule out choroidal pathologies, especially melanoma. This is essential as the management and prognosis of the two disorders is entirely different.
ABSTRACT
A 44-year-old female presented with central vision loss and photopsia in both eyes since 2 months. Multimodal imaging, field defects, electroretinogram abnormalities, and spectral domain optical coherence tomography changes were all suggestive of acute zonal occult outer retinopathy. En-face optical coherence tomography angiography (OCTA) images demonstrated hyper-reflective dots at the level of ellipsoid zone in both eyes in the presence of normal retinochoroidal vasculature. The patient was started on oral azathioprine and prednisolone. On two consecutive monthly follow-ups, en-face OCTA images demonstrated serial changes in the hyper-reflective dot morphology at ellipsoid zone level that have not been previously reported in the literature.
Subject(s)
Fluorescein Angiography/methods , Multimodal Imaging , Retina/pathology , Scotoma/diagnosis , Tomography, Optical Coherence/methods , Adult , Female , Fundus Oculi , Humans , Reproducibility of Results , Visual Acuity , White Dot SyndromesABSTRACT
The classic entity of autosomal dominant Blau syndrome (BS) consists of arthritis, dermatitis, and uveitis, occurring as a result of mutations in the NOD2 gene pattern recognition receptor. Sporadic cases are those in which no known gene mutation is identifiable. Uveitis in BS can be refractory to conventional therapy. We report a case of sporadic Blau uveitis managed with adalimumab monotherapy after failing to respond to topical steroids, systemic steroids, methotrexate, and infliximab therapy sequentially. Uveitis resolved completely with adalimumab and the patient has had a disease-free period over a 2-year follow-up with bi-monthly injections for arthritis control.
Subject(s)
Adalimumab/administration & dosage , Arthritis/complications , Synovitis/complications , Uveitis/etiology , Anti-Inflammatory Agents/administration & dosage , Arthritis/diagnosis , Arthritis/drug therapy , Child, Preschool , Dose-Response Relationship, Drug , Humans , Injections, Subcutaneous , Male , Sarcoidosis , Synovitis/diagnosis , Synovitis/drug therapy , Tomography, Optical Coherence , Uveitis/complications , Uveitis/diagnosis , Uveitis/drug therapyABSTRACT
A 60-year-old male presented with pain and decreased vision 3 weeks following uneventful intracapsular cataract extraction with anterior vitrectomy for subluxated cataract. A diagnosis of acute endophthalmitis was made based on clinical and ultrasound features. Patient improved only after undergoing pars plana vitrectomies twice and repeated intravitreal antibiotic-steroid injections. Vitreous aspirate revealed Gram-negative bacillus identified as Pseudomonas luteola on culture. Patient returned with a retinal detachment at first follow-up which was treated with vitrectomy, endolaser, and silicone oil tamponade. To the best of our knowledge, this is the first case of P. luteola causing acute onset, virulent endophthalmitis reported in literature.
